Nalbuphine
Nalbuphine is a semi-synthetic opioid analgesic developed in the early 1970s and is structurally related to both oxymorphone and naltrexone. It is used primarily in the management of moderate to severe pain. Nalbuphine belongs to the class of drugs known as mixed opioid receptor agonists-antagonists. This pharmacological profile provides nalbuphine with the ability to offer pain relief (analgesia) while reducing the risk of opioid-induced side effects such as respiratory depression and dependency, which are commonly associated with other opioids.
Pharmacology[edit | edit source]
Nalbuphine exerts its analgesic effects by acting on the mu-opioid receptor (MOR) and kappa-opioid receptor (KOR). It acts as an antagonist at the mu-opioid receptor and as an agonist at the kappa-opioid receptor. This unique mechanism of action contributes to its analgesic properties and lower risk of dependency compared to full mu-opioid agonists. The drug's action on kappa receptors also explains some of its side effects, such as psychotomimetic effects, which may include hallucinations and dysphoria in some patients.
Clinical Use[edit | edit source]
Nalbuphine is indicated for the relief of moderate to severe pain. It can be administered via intravenous, intramuscular, or subcutaneous routes. Due to its ceiling effect for respiratory depression, nalbuphine is considered safer than other opioids for use in high-risk patients, including those with compromised respiratory function. It is also used in obstetrics to alleviate pain during labor, as it does not significantly depress fetal heart rate.
Side Effects[edit | edit source]
Common side effects of nalbuphine include sedation, dizziness, nausea, vomiting, and sweating. Unlike many other opioids, nalbuphine has a lower risk of causing significant respiratory depression and has a reduced potential for abuse and addiction. However, its use can still lead to the development of tolerance and withdrawal symptoms upon abrupt discontinuation.
Contraindications[edit | edit source]
Nalbuphine is contraindicated in patients with known hypersensitivity to the drug. Caution is advised when administering nalbuphine to patients with impaired renal or hepatic function, as it may require dose adjustments. It should also be used with caution in patients with a history of substance abuse or mental health disorders.
Comparison with Other Opioids[edit | edit source]
Nalbuphine's unique receptor profile distinguishes it from other opioids. Its ability to provide analgesia with a reduced risk of respiratory depression and lower abuse potential makes it a valuable option in certain patient populations. However, its efficacy in managing pain is not superior to that of full mu-opioid agonists, and its use may be limited by side effects such as dysphoria and hallucinations.
Conclusion[edit | edit source]
Nalbuphine is an important tool in the management of pain, offering a balance between efficacy and safety. Its role in clinical practice is particularly valuable in situations where the risk of respiratory depression or opioid abuse is a significant concern. Ongoing research and clinical experience will continue to define the optimal use of nalbuphine in pain management.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD